Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities

Rationale: Osteoporosis is a severe bone disorder that is a threat to our aging population. Excessive osteoclast formation and bone resorption lead to changes in trabecular bone volume and architecture, leaving the bones vulnerable to fracture. Therapeutic approaches of inhibiting osteoclastogenesis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Theranostics
Egile Nagusiak: Liu, Yuhao, Wang, Chao, Wang, Gang, Sun, Youqiang, Deng, Zhangrong, Chen, Leilei, Chen, Kai, Tickner, Jennifer, Kenny, Jacob, Song, Dezhi, Zhang, Qingwen, Wang, Haibin, Chen, Zhenqiu, Zhou, Chi, He, Wei, Xu, Jiake
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2019
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6643439/
https://ncbi.nlm.nih.gov/pubmed/31367247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35414
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak